Tracey McCain's most recent trade in Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A was a trade of 16,798 Share Option done . Disclosure was reported to the exchange on June 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 16,798 | 16,798 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 3,173 | 12,546 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 3,173 | 0 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 2,799 | 2,799 | - | - | Restricted Share Units | |
| Blueprint Medicines Corp | Tracey L. McCain | EVP AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 88.80 per share. | 05 Mar 2025 | 5,262 | 66,583 (0%) | 0% | 88.8 | 467,266 | Common Stock |
| Blueprint Medicines Corp | Tracey L. McCain | EVP AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Tracey L. McCain | EVP AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 11,000 | 71,845 (0%) | 0% | 0 | Common Stock | |
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 19,040 | 19,040 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 4,373 | 9,373 (0%) | 0% | - | Class A Common Share | |
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2024 | 4,373 | 0 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 3,173 | 3,173 | - | - | Restricted Share Units | |
| Blueprint Medicines Corp | Tracey L. McCain | EVP AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 90.69 per share. | 07 Mar 2024 | 5,194 | 60,498 (0%) | 0% | 90.7 | 471,044 | Common Stock |
| Blueprint Medicines Corp | Tracey L. McCain | EVP AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Tracey L. McCain | EVP AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 12,500 | 65,692 (0%) | 0% | 0 | Common Stock | |
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 5,000 | 0 | - | - | Restricted Share Units | |
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 5,000 | 5,000 (0%) | 0% | - | Class A Common Share | |
| Immunogen, Inc. | Tracey L. McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 19,597 | 19,597 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Tracey L. McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 13,090 | 13,090 | - | - | Restricted Stock Unit | |
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 26,236 | 26,236 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Tracey L. McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 4,373 | 4,373 | - | - | Restricted Share Units | |
| Blueprint Medicines Corp | Tracey L. McCain | EVP AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 45.72 per share. | 06 Mar 2023 | 3,216 | 52,772 (0%) | 0% | 45.7 | 147,036 | Common Stock |
| Blueprint Medicines Corp | Tracey L. McCain | EVP AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 44.41 per share. | 06 Mar 2023 | 106 | 52,666 (0%) | 0% | 44.4 | 4,707 | Common Stock |
| Blueprint Medicines Corp | Tracey L. McCain | EVP AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Tracey L. McCain | EVP AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 12,500 | 55,988 (0%) | 0% | 0 | Common Stock | |
| Immunogen, Inc. | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 2,772 | 50,303 | - | - | Deferred Share Unit | |
| Immunogen, Inc. | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 2,876 | 47,531 | - | - | Deferred Share Unit | |
| Immunogen, Inc. | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 3,055 | 44,655 | - | - | Deferred Share Unit | |
| Kiniksa Pharmaceuticals Lt... | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 30,000 | 30,000 | - | - | Share Option | |
| Kiniksa Pharmaceuticals Lt... | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2022 | 5,000 | 5,000 | - | - | Restricted Share Units | |
| Immunogen, Inc. | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,556 | 25,556 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 8,712 | 41,600 | - | - | Deferred Share Unit | |
| Immunogen, Inc. | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 2,888 | 32,888 | - | - | Deferred Share Unit | |
| Blueprint Medicines Corp | Tracey McCain | EVP AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.28 per share. | 03 Mar 2022 | 1,667 | 44,274 (0%) | 0% | 60.3 | 100,487 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP AND CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 56.19 per share. | 03 Mar 2022 | 1,047 | 43,227 (0%) | 0% | 56.2 | 58,831 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Tracey McCain | EVP AND CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 12,500 | 45,941 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2021 | 5,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.36 per share. | 07 Dec 2021 | 5,000 | 38,441 (0%) | 0% | 28.4 | 141,800 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 97.46 per share. | 07 Dec 2021 | 4,328 | 34,113 (0%) | 0% | 97.5 | 421,807 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 96.38 per share. | 07 Dec 2021 | 572 | 33,541 (0%) | 0% | 96.4 | 55,129 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 95.54 per share. | 07 Dec 2021 | 100 | 33,441 (0%) | 0% | 95.5 | 9,554 | Common Stock |
| Immunogen, Inc. | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2021 | 30,000 | 30,000 | - | - | Deferred Share Unit | |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2021 | 5,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.36 per share. | 03 Nov 2021 | 5,000 | 38,274 (0%) | 0% | 28.4 | 141,800 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 110.74 per share. | 03 Nov 2021 | 4,200 | 34,074 (0%) | 0% | 110.7 | 465,108 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 109.63 per share. | 03 Nov 2021 | 800 | 33,274 (0%) | 0% | 109.6 | 87,704 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.36 per share. | 23 Sep 2021 | 25,000 | 58,274 (0%) | 0% | 28.4 | 709,000 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Sep 2021 | 25,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 108.78 per share. | 23 Sep 2021 | 17,317 | 36,195 (0%) | 0% | 108.8 | 1,883,743 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 109.80 per share. | 23 Sep 2021 | 4,762 | 53,512 (0%) | 0% | 109.8 | 522,868 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 107.75 per share. | 23 Sep 2021 | 2,921 | 33,274 (0%) | 0% | 107.8 | 314,738 | Common Stock |
| Kiniksa Pharmaceuticals Lt... | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 33,237 | 33,237 | - | - | Share Option | |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 86.61 per share. | 04 Mar 2021 | 1,772 | 32,852 (0%) | 0% | 86.6 | 153,473 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 89.00 per share. | 04 Mar 2021 | 121 | 34,624 (0%) | 0% | 89 | 10,769 | Common Stock |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 26,125 | 26,125 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Tracey McCain | EVP and Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 13,062 | 34,745 (0%) | 0% | 0 | Common Stock | |
| Kiniksa Pharmaceuticals Lt... | Tracey McCain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 18,760 | 18,760 | - | - | Share Option |